> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Vir Biotechnology
- URL: https://www.whiteroseintelligence.com/vir-biotechnology/
- Published: 2026-07-25T19:20:00.000Z
- Updated: 2026-07-25T19:21:10.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization, Organization, #toc, Biotechnology, United States, California, COVID-19, Pharmaceutical

**Vir Biotechnology** is an American biotechnology company based in San Francisco, California.

## COVID-19

Vir Biotechnology is a participating organization in the [Accelerating COVID-19 Therapeutic Interventions and Vaccines](https://www.whiteroseintelligence.com/Accelerating-COVID-19-Therapeutic-Interventions-and-Vaccines) (ACTIV) initiative.[\[1\]](#fn1)

On April 7, 2020, Vir Biotechnology and GlaxoSmithKline announced that they had entered an agreement to collaborate on SARS-CoV-2 monoclonal antibody and [COVID-19 vaccine](https://www.whiteroseintelligence.com/COVID-19-vaccine) products.[\[2\]](#fn2)

## Partners

Vir Biotechnology is partnered with:[\[3\]](#fn3)

- [Alnylam Pharmaceuticals](https://www.whiteroseintelligence.com/Alnylam-Pharmaceuticals)
- [Bill & Melinda Gates Foundation](https://www.whiteroseintelligence.com/Bill-Melinda-Gates-Foundation)
- [Brii Biosciences](https://www.whiteroseintelligence.com/Brii-Biosciences)
- Gilead Sciences
- GlaxoSmithKline
- Institute for Research in Biomedicine (IRB)
- Oregon Health & Science University (OHSU)

## Investors

Investors in Vir Biotechnology include:[\[4\]](#fn4)[\[2:1\]](#fn2)

- [Alta Partners](https://www.whiteroseintelligence.com/Alta-Partners)
- Altitude Life Science Ventures
- ARCH Venture Partners
- [Bill & Melinda Gates Foundation](https://www.whiteroseintelligence.com/Bill-Melinda-Gates-Foundation)
- GlaxoSmithKline
- [Section 32](https://www.whiteroseintelligence.com/Section-32)[\[5\]](#fn5)
- SoftBank Vision Fund

## External links

- [Crunchbase](https://www.crunchbase.com/organization/vir-biotechnology)
- [Website](https://www.vir.bio/)

---

1. *ACTIV.* National Institutes of Health (NIH). Retrieved April 1, 2022, from <http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ> [↩︎](#fnref1)
2. Chowdhry, A. (2020, April 7). *GlaxoSmithKline Invests $250 Million In Vir Biotechnology As Part Of A Strategic Deal.* Pulse 2.0\. <https://web.archive.org/web/20230710162820/https://pulse2.com/glaxosmithkline-invests-250-million-in-vir-biotechnology-as-part-of-a-strategic-deal/> [↩︎](#fnref2) [↩︎](#fnref2:1)
3. *Development Pipeline.* Vir Biotechnology. Retrieved June 5, 2023, from <https://web.archive.org/web/20230605065123/https://www.vir.bio/pipeline/#collab> [↩︎](#fnref3)
4. *Venture Round - Vir Biotechnology - 2017-01-06 - Crunchbase Funding Round Profile.* Crunchbase. Retrieved July 10, 2023, from <https://www.crunchbase.com/funding%5Fround/vir-biotechnology-series-unknown--4be38a50> [↩︎](#fnref4)
5. *About.* S32\. Retrieved July 29, 2023, from <https://www.s32.com/#about> [↩︎](#fnref5)